Crossroads Capital Investments Bet on Nebius Group NBIS Gains Traction Precious Metals Decline Gold Silver Fall Amid Market Uncertainty Healthcare Technology Transformation Sensors Wearables and Personalized Medicine Reshaping Clinical Care April Jobs Report Expected to Show Cooling Yet Resilient Labor Market Indian Benchmarks Hit Highest Close Since April on West Asia Developments The Mandalorian and Grogu Achieves Record Rotten Tomatoes Audience Score Amid CriticAudience Divide RIME Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Surges WTW Q1 2026 Earnings Adjusted EPS Edges Past Estimates as Stock Holds Steady RNST Q1 2026 Earnings EPS Beats Estimates by 811 Stock Declines Slightly PRHIZ Q1 2024 Earnings Significant EPS Beat Surprises Markets TRINZ Q1 2026 Earnings Slight EPS Beat Amid Cautious Market Reaction Science Applications International SAIC Edges Higher Amid Defense Sector Resilience Key Levels in Focus Evolution Global Acquisition Corp Units EVOXU Holds Steady at 1017 Amid Consolidation Rapport Therapeutics RAPP Holds Steady as Minor Decline Tests Key Support Levels Nebius Group NBIS Holds Near 208 as Investors Weigh Narrow Trading Range SAB Biotherapeutics SABS Slides 381 as Biotech Sector Faces Headwinds Key Support Tested Indias Sugar Export Ban Forex Pressure Drives Policy Shift Global Market Implications KEP Q4 2025 Earnings EPS Misses Estimates Amid Cost Pressures Stock Slips SMX Stock Climbs 265 as Shares Test Key Resistance at 815